Literature DB >> 20102354

The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States.

N Thukkani1, A Sonnenberg.   

Abstract

BACKGROUND: The impact of gastro-oesophageal reflux disease on hospitalization is unknown. AIM: To describe the characteristics of patients hospitalized for diagnoses related to gastro-oesophageal reflux disease (GERD) and find potential environmental influences that affect their hospitalization.
METHODS: Data from the Healthcare Cost and Utilization Project were used to study the demographic characteristics of hospitalizations associated with GERD during 2003-2006. Data from the Centers for Disease Control were used for information about the US prevalence of obesity.
RESULTS: During 2003-2006, 0.5 million patients with a primary and 14.5 million patients with a secondary GERD-related diagnosis became hospitalized in the US. Oesophageal reflux and hiatal hernia were more common in female than in male inpatients, whereas Barrett's oesophagus and oesophageal adenocarcinoma were more common in male than in female inpatients. All GERD-related diagnoses were more common in white people than non-white people. Hospitalizations associated with oesophageal reflux, reflux oesophagitis and Barrett's oesophagus showed resembling geographical distributions among different US states. The prevalence of obesity and the hospitalization for hiatal hernia or reflux oesophagitis were also characterized by similar geographical distributions.
CONCLUSION: The large numbers of inpatients with a discharge diagnosis of GERD-related conditions attest to the frequent occurrence and relevance of GERD in contributing to hospitalization in the US.

Entities:  

Mesh:

Year:  2010        PMID: 20102354     DOI: 10.1111/j.1365-2036.2010.04245.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach.

Authors:  Avi Rosenfeld; David G Graham; Sarah Jevons; Jose Ariza; Daryl Hagan; Ash Wilson; Samuel J Lovat; Sarmed S Sami; Omer F Ahmad; Marco Novelli; Manuel Rodriguez Justo; Alison Winstanley; Eliyahu M Heifetz; Mordehy Ben-Zecharia; Uria Noiman; Rebecca C Fitzgerald; Peter Sasieni; Laurence B Lovat
Journal:  Lancet Digit Health       Date:  2019-12-05

Review 2.  Presentation and Epidemiology of Gastroesophageal Reflux Disease.

Authors:  Joel E Richter; Joel H Rubenstein
Journal:  Gastroenterology       Date:  2017-08-03       Impact factor: 22.682

Review 3.  Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery?

Authors:  Vivek N Prachand; John C Alverdy
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  The Outcomes of Laparoscopic Biliopancreatic Diversion with Duodenal Switch on Gastro-esophageal Reflux Disease: the Mayo Clinic Experience.

Authors:  Joseph N Badaoui; Todd A Kellogg; Barham K Abu Dayyeh; Justin W Maroun; Travis J McKenzie; William S Harmsen; Michael L Kendrick; Omar M Ghanem
Journal:  Obes Surg       Date:  2021-07-22       Impact factor: 4.129

5.  The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?

Authors:  Takahisa Yamasaki; Colin Hemond; Mohamed Eisa; Stephen Ganocy; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

6.  Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus.

Authors:  Xinxue Liu; Angela Wong; Sudarshan R Kadri; Andrej Corovic; Maria O'Donovan; Pierre Lao-Sirieix; Laurence B Lovat; Rodney W Burnham; Rebecca C Fitzgerald
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.